Best Penny Stocks Under 5 Cents Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.05 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.05. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Syros Pharmaceuticals NASDAQ:SYRS$0.03 +0.00 (+20.69%) As of 12:06 PM EasternSyros Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. More about Syros PharmaceuticalsMarket Capitalization$751 thousandP/E Ratio-0.01Consensus RatingHoldConsensus Price Target$3.33 (+11,804.8% Upside)Volume47,430 sharesAverage Volume8.06 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Cutera NASDAQ:CUTR$0.04 -0.07 (-63.86%) Closing price 03/12/2025Extended Trading$0.04 0.00 (0.00%) As of 03/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. More about CuteraMarket Capitalization$787 thousandP/E Ratio-0.01Consensus RatingModerate BuyConsensus Price Target$3.00 (+7,592.3% Upside)Volume27.70 million sharesAverage Volume2.76 million shares3. Cannabist OTCMKTS:CBSTF$0.05 0.00 (-3.33%) As of 12:03 PM EasternThe Cannabist Company Holdings Inc engages in the cultivation, development, production, home delivery, and dispensary of cannabis products in the United States and internationally. More about CannabistConsensus RatingHoldVolume140,287 sharesAverage Volume734,152 sharesToday's Range$0.05▼$0.0550-Day Range$0.04▼$0.0852-Week Range$0.03▼$0.314. BIOLASE NASDAQ:BIOL$0.01 +0.00 (+13.21%) As of 06/30/2025BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. More about BIOLASEMarket Capitalization$401 thousandP/E Ratio0.00Consensus RatingBuyConsensus Price Target$1.20 (+9,900.0% Upside)Volume89,800 sharesAverage Volume2.58 million shares5. Ascot Resources OTCMKTS:AOTVF$0.04 0.00 (-5.47%) As of 11:54 AM EasternAscot Resources Ltd. engages in the exploration, evaluation, and development of mineral properties in the United States and Canada. More about Ascot ResourcesConsensus RatingHoldVolume327,840 sharesAverage Volume679,194 sharesToday's Range$0.04▼$0.0550-Day Range$0.04▼$0.0952-Week Range$0.04▼$0.466. Nextech3D.AI OTCMKTS:NEXCF$0.04 -0.01 (-12.32%) As of 12:08 PM EasternNextech3D.AI Corporation provides augmented reality technologies, wayfinding technologies, and 3D model services. It focuses on creating 3D WebAR photorealistic models for the prime ecommerce marketplace, as well as other online retailers. More about Nextech3D.AIMarket Capitalization$6.23 millionP/E Ratio-1.09Consensus RatingBuyConsensus Price Target$0.25 (+476.0% Upside)Volume1.39 million sharesAverage Volume632,494 shares7. Vincerx Pharma NASDAQ:VINC$0.04 0.00 (-5.56%) As of 10:53 AM EasternVincerx Pharma, Inc, a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. More about Vincerx PharmaMarket Capitalization$222 thousandP/E Ratio0.00Consensus RatingBuyConsensus Price Target$40.00 (+94,017.6% Upside)Volume1,301 sharesAverage Volume436,813 shares8. Viracta Therapeutics NASDAQ:VIRX$0.02 0.00 (-8.54%) As of 11:51 AM EasternViracta Therapeutics, Inc, a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. More about Viracta TherapeuticsMarket Capitalization$596 thousandP/E Ratio-0.01Consensus RatingHoldConsensus Price Target$1.75 (+11,566.7% Upside)Volume20,673 sharesAverage Volume1.08 million shares9. Exro Technologies OTCMKTS:EXROF$0.05 0.00 (-5.24%) As of 12:10 PM EasternExro Technologies Inc focuses on developing generation power-control electronics in Canada. The company offers Exro Coil Driver, which allows the motor to switch between different operational profiles in real-time, as well as have multiple gears for scooters, electric bikes, recreational, light electric cars, motorcycles, fleet vans, electric buses, passenger vehicles, long-haul trucks, and industrial vehicles markets; and Exro Cell Driver, a stationary energy storage system for commercial and industrial energy storage applications. More about Exro TechnologiesMarket Capitalization$26.30 millionP/E Ratio-0.11Consensus RatingReduceVolume99,078 sharesAverage Volume279,736 sharesToday's Range$0.05▼$0.0510. Crypto OTCMKTS:CRCW$0.0008 0.00 (-11.11%) As of 11:56 AM EasternThe Crypto Company does not have significant operations. It was previously involved in the provision of consulting and education services for distributed ledger technologies, for the building of technological infrastructure, and enterprise blockchain technology solutions. More about CryptoConsensus RatingModerate BuyVolume3.92 million sharesAverage Volume12.51 million sharesToday's Range$0.0008▼$0.000950-Day Range$0.0006▼$0.001152-Week Range$0.0005▼$0.001611. Zapata Computing NASDAQ:ZPTA$0.02 0.00 (0.00%) As of 09:42 AM EasternZapata Computing Holdings Inc operates as an industrial generative artificial intelligence (AI) software company in the United States. More about Zapata ComputingMarket Capitalization$773 thousandConsensus RatingBuyConsensus Price Target$1.63 (+8,025.0% Upside)Volume962 sharesAverage Volume163,890 sharesToday's Range$0.02▼$0.0212. Medicine Man Technologies OTCMKTS:SHWZ$0.0020 0.00 (0.00%) As of 07/1/2025Medicine Man Technologies, Inc, doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. More about Medicine Man TechnologiesConsensus RatingBuyConsensus Price Target$2.50 (+124,900.0% Upside)Volume40 sharesAverage Volume9,556 sharesToday's Range$0.0020▼$0.002050-Day Range$0.00▼$0.03 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Dan Ives’ Bold $5 Trillion Forecast for Microsoft Stock 3 Utility Stocks That Combine Income and Stability 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Toast Stock: A Fast-Growing Mid-Cap Eyeing Further Upside Breakout Alert: Disney Stock Hits Multi-Year High 2 Under the Radar Space & Defense Stocks With Huge Potential Why Realty Income’s 5.59% Yield Makes It a Must-Buy REIT Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
